London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is what we all should be focusing on.. why would DIRECTORS sell their shares if they thought the long term plan was robust.. you can't deny these facts.... THEY SHOULD BE BUYING HUGE AMOUNTS TO GIVE THE MARKET CONFIDENCE IN THEIR OWN ABILITIES - which they are not..
SkinBioTherapeutics Director dealings
Trade date Director Volume / Price Trade value Trade type
06/04/2023 Manprit Singh Randhawa 66,778 @ 16.00p £10,684.48 Sell
06/04/2023 Stuart Ashman 123,878 @ 16.25p £20,130.18 Sell
Stuart Ashman, CEO and PDMR, sold 123,878 ordinary shares of 1p each in the Company ("Ordinary Shares") and repurchased 122,517 Ordinary Shares into Mr Ashman's ISA account. Following this transaction Stuart Ashman's beneficial interest in the Company shares has reduced by 1,361 ordinary shares.
In addition, Manprit Randhawa, CFO and PDMR, sold 66,778 Ordinary Shares and repurchased 66,778 Ordinary Shares into Mr Randhawa's ISA account. Following this transaction Manprit Randhawa's beneficial interest in the Company shares has not changed.
Well said Nick1978. Very much a misunderstanding by Elonmusky9. The 2 directors sold into their ISA's which is a smart move. This happens in every company.
His motive was obvious, didn’t take long for the wheels to fall off. Lmao!
So boring these people.
Well the wheels have fallen off the share price and Ashman has still to take remedial action.
Stuart Ashman and his extortionate salary while actually giving miniscule shareholder returns with little hope at current rates is the cause of the problem.
Overpaid pigs gorging at shareholders expense with no real skin in the game. Its the classic "sounds a brill product, going to milk them shareholders to death"..
CEO worth his salt would have slashed his remuneration till profits materialised, unless he doesn't think they actually will?
One things for sure... Glad I never listened to some some that charge for advice here....my calcs show i'd have lost 150k, if I had at current prices.
Belgrano, my thoughts entirely. I would have had a much better feeling if he had awarded himself a share option target rise instead of money in his pocket. That said I’m still in , I believe in the product and although I’m disappointed in some of his decision making I think he is pushing the company forward… just wish he and Manprit had held back on filling their pockets so soon.
The Chief Scientific Officer has still to comment on Dermatonics products and the fit within Skin.
Thomas, what do you expect her to say? I know you like to throw in negative posts but you’re sounding desperate to find something now.
Why would it be unusual for the Scientific Officer not to make a comment on the new product line. I hold Prof. O'Neill in high esteem, but not with the vastly overpaid BoD's.
Some Belgrano quotes in the light of current behaviour :
"when investors have sold up completely and still continue to post negative viewpoints in order to put off others or try and drop the price in my book that poster is a troll."
"If you can't say anything positive please don't say anything at all"
At 18p - "to buy would be better as I believe its (sic) oversold" "the only way is up"
"any stock purchased sub 25p is a bargain"
i don;t mind paying tw for advice. the decision to buy or sell is my choise on the timing. i am paying for time saved on research. as for you cals, they mean nothing, its bs statement. you may as well have claimed you never make a wrong investment decision. your exposed for what you are, a devious troll waiting to pile in at a lower price. the bargain price you have suggested before have seen new lows so you are back after finding your buys are under water. we see you for you really are belgrano. you are worse than those trolls ******** about the same person time and time again. your are a leach.
The cso is a lab person and not full time staff. The people that need to discuss Dermatonics is Greg, Stuart, Manptret. The only role the cso has is validating the products as being worth adding and is the ip a good fit for adding inside existing products.
Ahhh just spotted your post gibson, glad you have the time to actually troll though al my previous posts then extract parts out of context to attempt to slander the poster rather than discuss issues. Expect if you went back even further there might be a lot more beauties as well, because we call things as we see them at the time, and when more factual sales figs come to light, or annual accounts show that a company is not likely to be profitable in the foreseeable, and will require further share rights issues just to pay the salaries of greedy management that are not delivering on promise.
Am I a "devious troll wanting waiting to pile back in at a lower price"... as you claim, or a shrewd investor who didn't like what he was seeing with this company and pulled out his investment, and kindly shared his thoughts with other investors. Its no secret that I've posted many highly positive things about this company previously and have been accused of ramping, or wearing rosy sunglasses a few times. Just because fortunes have turned its no reason to try and discredit a serious investor because you are in fact jealous of my actions and also wish you had also withdrawn and clearly missed the warning signs.
You claim I'm waiting to get back in.. well I'll honestly answer that right now, and as I see it today, I wouldn't touch it with a barge pole until I see solid proof of sales, proof that yet more rights issues will be needed, and proof that our management team are not just trying to get as much out of this company until the music stops.
I love the products and that's the kicker, just that its potential is just scratching the surface, and under current leadership I cant see how they are going to achieve solid market traction before going under.
Please let me know your views on this PGlancy, and leave the personal attacks in the garbage pls.
“and kindly shared his thoughts with other investors” OMG you have to laugh, can’t believe we’re still having to surfer this pompous blowhard even though he is out. Kindly do us all a favour and f off.
Belgrano - I was simply prompted by your saying that you were glad you hadn't taken 'paid' advice on SBTX as you would have lost a lot of money. When this was over 20p you were advising Opti holders to sell up and buy SBTX - how much money would THEY have lost because of you - as opposed to a 30% gain on Opti. You are a troll with no shame but always respond with feigned self-righteous indignation when people see you for what you are and call you out.
Belgrano, I was simply prompted by your post that you were glad you hadn't taken 'paid' advice here as you would have lost a lot of money. When this was over 20p you encouraged Opti investors to sell up and buy SBTX - how much would they have lost because of your advice - as opposed to a 30% gain on Opti. You always react with feigned self-righteous indignation when called out - hopefully nobody is foolish enough to fall for this anymore.
Hi Gibson, thanks for the post, please leave abuse in the garbage.
Look what one poster wrote when the shareprice was 53p. Now the shareprice is over 700 percent lower , do you actually still stand by your words.
clearly the market does not agree.
"Look at the performance of the company and its trajectory at this early stage of commercialisation and you won't begrudge the salaries - they're working rather than just posting on share chat boards. The sp is disappointing of course and many are under water but traders will sell once too often and will not be able to continue to damage the sp before long. This company is sound and nothing like the Aim non-achievers."